207 related articles for article (PubMed ID: 32401801)
1. Anti-cancer effects of Bifidobacterium species in colon cancer cells and a mouse model of carcinogenesis.
Asadollahi P; Ghanavati R; Rohani M; Razavi S; Esghaei M; Talebi M
PLoS One; 2020; 15(5):e0232930. PubMed ID: 32401801
[TBL] [Abstract][Full Text] [Related]
2. EGFR, HER-2 and COX-2 levels in colorectal cancer.
Antonacopoulou AG; Tsamandas AC; Petsas T; Liava A; Scopa CD; Papavassiliou AG; Kalofonos HP
Histopathology; 2008 Dec; 53(6):698-706. PubMed ID: 19102009
[TBL] [Abstract][Full Text] [Related]
3. Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells.
Ahmed M; Hussain AR; Siraj AK; Uddin S; Al-Sanea N; Al-Dayel F; Al-Assiri M; Beg S; Al-Kuraya KS
Mol Cancer; 2015 Jul; 14():131. PubMed ID: 26159723
[TBL] [Abstract][Full Text] [Related]
4. Deficient HER3 expression in poorly-differentiated colorectal cancer cells enhances gefitinib sensitivity.
Nakata S; Tanaka H; Ito Y; Hara M; Fujita M; Kondo E; Kanemitsu Y; Yatabe Y; Nakanishi H
Int J Oncol; 2014 Oct; 45(4):1583-93. PubMed ID: 25017791
[TBL] [Abstract][Full Text] [Related]
5. A randomized double-blind placebo-controlled trial of probiotics in post-surgical colorectal cancer.
Zaharuddin L; Mokhtar NM; Muhammad Nawawi KN; Raja Ali RA
BMC Gastroenterol; 2019 Jul; 19(1):131. PubMed ID: 31340751
[TBL] [Abstract][Full Text] [Related]
6. Probiotic Dahi containing Lactobacillus acidophilus and Bifidobacterium bifidum modulates the formation of aberrant crypt foci, mucin-depleted foci, and cell proliferation on 1,2-dimethylhydrazine-induced colorectal carcinogenesis in Wistar rats.
Mohania D; Kansal VK; Kruzliak P; Kumari A
Rejuvenation Res; 2014 Aug; 17(4):325-33. PubMed ID: 24524423
[TBL] [Abstract][Full Text] [Related]
7. Lactobacillus species inhibitory effect on colorectal cancer progression through modulating the Wnt/β-catenin signaling pathway.
Ghanavati R; Akbari A; Mohammadi F; Asadollahi P; Javadi A; Talebi M; Rohani M
Mol Cell Biochem; 2020 Jul; 470(1-2):1-13. PubMed ID: 32419125
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic effects of secretion metabolites of dairy lactobacilli through downregulation of ErbB-2 and ErbB-3 genes on colon cancer cells.
Faghfoori Z; Pourghassem Gargari B; Saber A; Seyyedi M; Fazelian S; Khosroushahi AY
Eur J Cancer Prev; 2020 May; 29(3):201-209. PubMed ID: 28683007
[TBL] [Abstract][Full Text] [Related]
9. Bifidobacterium longum Suppresses Murine Colorectal Cancer through the Modulation of oncomiRs and Tumor Suppressor miRNAs.
Fahmy CA; Gamal-Eldeen AM; El-Hussieny EA; Raafat BM; Mehanna NS; Talaat RM; Shaaban MT
Nutr Cancer; 2019; 71(4):688-700. PubMed ID: 30862187
[TBL] [Abstract][Full Text] [Related]
10. miR-145-5p restrained cell growth, invasion, migration and tumorigenesis via modulating RHBDD1 in colorectal cancer via the EGFR-associated signaling pathway.
Niu Y; Zhang J; Tong Y; Li J; Liu B
Int J Biochem Cell Biol; 2019 Dec; 117():105641. PubMed ID: 31693935
[TBL] [Abstract][Full Text] [Related]
11. Toxicological Evaluation of a Probiotic-Based Delivery System for P8 Protein as an Anti-Colorectal Cancer Drug.
An BC; Yoon YS; Park HJ; Park S; Kim TY; Ahn JY; Kwon D; Choi O; Heo JY; Ryu Y; Kim JH; Eom H; Chung MJ
Drug Des Devel Ther; 2021; 15():4761-4793. PubMed ID: 34866901
[TBL] [Abstract][Full Text] [Related]
12. Lidocaine inhibits proliferation and induces apoptosis in colorectal cancer cells by upregulating mir-520a-3p and targeting EGFR.
Qu X; Yang L; Shi Q; Wang X; Wang D; Wu G
Pathol Res Pract; 2018 Dec; 214(12):1974-1979. PubMed ID: 30262429
[TBL] [Abstract][Full Text] [Related]
13. A Probiotic Formula for Modulation of Colorectal Cancer Risk via Reducing CRC-Associated Bacteria.
Liang JQ; Zeng Y; Lau EYT; Sun Y; Huang Y; Zhou T; Xu Z; Yu J; Ng SC; Chan FKL
Cells; 2023 Apr; 12(9):. PubMed ID: 37174650
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous targeting of the epidermal growth factor receptor and cyclooxygenase-2 pathways for pancreatic cancer therapy.
Ali S; El-Rayes BF; Sarkar FH; Philip PA
Mol Cancer Ther; 2005 Dec; 4(12):1943-51. PubMed ID: 16373709
[TBL] [Abstract][Full Text] [Related]
15. Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens.
Hütt P; Shchepetova J; Lõivukene K; Kullisaar T; Mikelsaar M
J Appl Microbiol; 2006 Jun; 100(6):1324-32. PubMed ID: 16696680
[TBL] [Abstract][Full Text] [Related]
16. Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats.
Femia AP; Luceri C; Dolara P; Giannini A; Biggeri A; Salvadori M; Clune Y; Collins KJ; Paglierani M; Caderni G
Carcinogenesis; 2002 Nov; 23(11):1953-60. PubMed ID: 12419846
[TBL] [Abstract][Full Text] [Related]
17. Concurrent inhibition of NF-kappaB, cyclooxygenase-2, and epidermal growth factor receptor leads to greater anti-tumor activity in pancreatic cancer.
Ali S; Banerjee S; Schaffert JM; El-Rayes BF; Philip PA; Sarkar FH
J Cell Biochem; 2010 May; 110(1):171-81. PubMed ID: 20213764
[TBL] [Abstract][Full Text] [Related]
18. Antitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer model.
Diaz R; Nguewa PA; Parrondo R; Perez-Stable C; Manrique I; Redrado M; Catena R; Collantes M; Peñuelas I; Díaz-González JA; Calvo A
BMC Cancer; 2010 May; 10():188. PubMed ID: 20459769
[TBL] [Abstract][Full Text] [Related]
19. Structural Change in Microbiota by a Probiotic Cocktail Enhances the Gut Barrier and Reduces Cancer via TLR2 Signaling in a Rat Model of Colon Cancer.
Kuugbee ED; Shang X; Gamallat Y; Bamba D; Awadasseid A; Suliman MA; Zang S; Ma Y; Chiwala G; Xin Y; Shang D
Dig Dis Sci; 2016 Oct; 61(10):2908-2920. PubMed ID: 27384052
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic intervention of probiotics (L.acidophilus, L.rhamnosus GG) and celecoxib modulate Bax-mediated apoptosis in 1,2-dimethylhydrazine-induced experimental colon carcinogenesis.
Sharaf LK; Sharma M; Chandel D; Shukla G
BMC Cancer; 2018 Nov; 18(1):1111. PubMed ID: 30424722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
